Strategic Partnerships Evidence of recent partnerships with Telefonica and Columna Capital signals a growing appetite for collaboration with tech and financial investors, presenting opportunities to position Evidenze as a partner for large-scale, data-driven clinical trials and European market expansion.

Data Space Platform The launch of Nefro Data Space in collaboration with hospitals and tech partners highlights a capability to offer data-centric solutions; explore cross-selling of data management, analytics, and trial optimization services to pharma clients seeking integrated data ecosystems.

Global Value CRO Position as a full value CRO with global reach and advanced technology to address regulatory success, cost optimization, and trial acceleration; target multinational sponsors seeking end-to-end performance and regulatory assurance.

Financial Scale Current revenue range places Evidenze in a mid-market tier with room for growth; pursue new mid-to-large sponsor accounts and regional expansions in Europe leveraging recent funding activity and strategic investments.

Tech-Driven Advantage Emphasize the tech stack and data platforms as differentiators for faster trial insights, risk management, and patient data integration; offer targeted solutions around data integration, analytics, and cloud-based trial ecosystems to drive sales with tech-forward sponsors.